-+ 0.00%
-+ 0.00%
-+ 0.00%

*Macrogenics Sees Lorigerlimab Phase 2 LINNET Study Update in Mid-2026 >MGNX

Dow Jones·03/09/2026 20:02:00

Please log in to view news